Endometrial mucinous adenocarcinoma
MONDO:0002747A primary, usually low grade adenocarcinoma of the endometrium in which the majority of the malignant epithelial cells contain abundant intracytoplasmic mucin.
Also known as: endometrial mucinous adenocarcinoma, endometrium mucinous adenocarcinoma, uterine corpus mucinous adenocarcinoma, uterine mucinous carcinoma
2859 clinical trials for this condition and its sub-types, 2 tagged with Endometrial mucinous adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Immunotherapy duo shows promise for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis phase II trial is testing whether combining two immunotherapy drugs, nivolumab and ipilimumab, works better than nivolumab alone for women with recurrent endometrial cancer that has a specific DNA repair defect (dMMR). About 81 participants will receive either the combinatio…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 13:00 UTC
-
Blood test may replace needles for endometrial cancer monitoring
Knowledge-focused Recruiting nowThis study is testing whether a blood test, called a liquid biopsy, can find cancer cells and predict if endometrial cancer will return. Researchers will collect blood and tissue samples from 1,000 women with endometrial cancer before and after treatment. The goal is to see if th…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC